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A new derivative of strychnopentamine was isolated from the leaves of S. usambarensis. This 
compound, named chrysopentamine, was identified by detailed spectroscopic methods (UV, 
IR, HRESIMS, 1D and 2D NMR). Chrysopentamine presented an original hydroxyl 
substitution on C-14 and an aromatization of the ring D of strychnopentamine leading to 
anhydronium base properties and exhibited strong antiplasmodial properties (IC50 inferior to 1 
µM). 
 Strychnos usambarensis Gilg (Loganiaceae) is a tree which has been used traditionally in the 
preparation of a curarizing arrow poison in Rwanda [1]. In addition to curarizing quaternary 
alkaloids, tertiary alkaloids showing antiplasmodial and cytotoxic activities were also found 
in the leaves and root bark [2-5] and, recently, we have showed that isostrychnopentamine (2) 
induces apoptosis in colon cancer cells by an original p53-independent pathway [6]. In the 
course of the development of an effective procedure for the extraction of strychnopentamine 
(1) and isostrychnopentamine (2) from the leaves of S. usambarensis, we isolated a new 
anhydronium base showing potent antiplasmodial properties. This new compound was named 
chrysopentamine (3), based on the Greek word "chrysos" for gold or orange-yellow and on 
the analogy with strychnopentamine (five nitrogen atoms) (Fig. 1). 
 
The UV spectrum of 3 suggested a highly conjugated β-carbolinium chromophore.  A 
bathochromic shift was observed in alkaline solutions, suggesting an anhydronium base 
moiety or/and a phenolic group. Despite the presence of a quaternary nitrogen in the 
corynanium part of the alkaloid, 3 was easily extractible by organic solvents under alkaline 
conditions (pH 8-9), indicating the presence of the zwitterionic form of an anhydronium base, 
as in dihydroflavopereirine (Fig. 1) [7].  The FT-IR spectrum showed NH and/or OH 
vibrations, vinyl vibrations, ortho disubstituted and ortho tetrasubstituted benzene vibrations, 
but no CO vibrations were detectable. Based on HRESI-MS, C35H38N5O2 was determined as 
the molecular formula, with a [M+H]+ at m/z 560.3044. This was indicative of the presence of 
five nitrogen atoms, one more than what was expected for a bisindole alkaloid.  
NMR spectral data of 3 are listed in Table 1. The broad band decoupled 13C NMR spectrum 
of 3 showed 35 carbon signals which were sorted by HSQC, HMBC and DEPT as two CH3, 
nine CH2, ten CH and 14 quaternary carbons. In the aromatic region, the COSY, TOCSY and 
HSQC spectra showed seven aromatic protons (represented by one four-spin system, one two-
spin system and a singlet at δ 7.77) and three protons from a vinylic side chain. The 1H and 
13C spectra of 3 were essentially similar to the spectra of 1 and 2 [8]. The principal differences 
with the 1 and 2 spectra were, in the aliphatic part of the 1H spectrum of 3, the absence of H-
3, H-14ab, H-15, H-20, H-21 and the deshielding of H-5, H-6, H-16 and H-17 and, in the 
aromatic part of the spectra, the appearance of a singlet at δ 7.77. This signal was correlated in 
the HMBC spectrum to C-5, C-20, C-19, C-3, C-2, C-15 and C-14, in the ROESY spectrum to 
H-5 and H-18, in the COSY spectrum to H-5 and H-19 and then attributed to H-21 (Table 1). 
The deshielded 1H and 13C shifts of CH-21 were consistent with those of strychnochrysine or 
afrocurarine, possessing a pyridinium ring D in their corynane moiety [9, 10]. The 
aromatization of ring D of strychnopentamine could explain the major other modifications 
compared to the spectra of 1 and 2. The HMBC spectrum allowed the assignment of the 
quaternary carbons of the pyridinium ring. The C-20 is correlated to H-21, H-18 and H-16b, 
while the C-15 is correlated to H-21 and H-16ab, C-3 is coupled to H-5 and H-21 and finally 
the C-14 is attributed to the quaternary signal at δ 160.9, which is correlated to H-16b and 
weakly with H-16a and H-21 (Table 1 and Fig. 3). This much deshielded value of C-14 could 
be explained by the presence of a hydroxyl substituent at this position. The presence of a 
supplementary hydroxyl substituent was expected from the HRESI-MS which has shown the 
presence of two oxygen atoms. This phenol at C-14 could also participate in the bathochromic 
shifts observed in the UV spectrum of 3 in alkaline conditions. The phenol at C-11 did not 
participate in the bathochromic shift, as it has been demonstrated that 1 and 2 possessed a 
cryptophenolic function and presented therefore no bathochromic shift [8]. Compound 3 
exhibited a stable brown-greenish coloration after detection with Fast Blue B reagent (phenol 
reagent) on TLC plates, while 1 and 2 presented only a transient purple coloration 
(consequence of the cryptophenolic function), which suggested the presence of supplementary 
phenolic function for 3.  This phenolic function could not be placed on the two indole 
moieties, because H-9, H-10, H-9´, H-10´, H-11´ and H-12´ were clearly identified by 
comparison with 1 and 2. The only possibility left was then the C-14 pyridinium position. To 
confirm the presence of two hydroxyl substitutions, 1H-NMR spectra of 1, 2 and 3 were 
recorded in CDCl3. The spectrum of 1 and 2 showed two extra NH peaks and one extra 
phenol peak at δ 11.80, while the spectrum of 3 exhibited two additional NH peaks and two 
additional phenol peaks at δ 10.60 (OH-14) and δ 11.44 (OH-11). An OH substitution on C-
14 is not very frequent for a corynane type alkaloid, but a 14-hydroxy-rauniticine has been 
previously described [11]. Finally, the linkage C-15/C-16/C-17 between the two portions of 
the molecule was confirmed by correlations in the HMBC spectrum (C-15/H-16b; C-14/H-
16b; C-20/H-16b; C-17/H-16b; C-17/H-5´ab) (Fig. 3) and in the COSY spectrum. The 
identity of the pyrrolidine ring was confirmed by correlations in the TOCSY spectrum (H-2´´-
H-3´´-H-4´´-H-5´´). 
The stereochemistry of 3 has still to be considered. The H-17β (C-17S) configuration was 
attributed by comparison of the CD spectra of 3 with those of 1 and 2 [2] and usambarine 
[12]. All these alkaloids gave a positive Cotton effect near 280 nm, which is indicative of a C-
17S configuration [13]. This stereochemistry is corroborated by the presence, in the ROESY 
spectrum of the same correlations for H-17 for 1, 2, and 3 (Table 1). The H-2´´α (C-2´´R) was 
proposed after comparison of the ROESY correlations of 3 with those of 1 (H-2´´α) and 2 (H-
2´´β). Compound 3 presented H-2´´ - H-11´ correlation as strychnopentamine (1), while 
isostrychnopentamine (2) exhibited an H-23 – H-11´ correlation, but no   H-2´´ - H-11´ 
correlation. These differences in ROESY couplings were consistent with strychnopentamine 
(1) and isostrychnopentamine (2) molecular modeling [8, 14]. 
The in vitro antiplasmodial activity of chrysopentamine (3) was determined against three 
Plasmodium falciparum cell lines in comparison to chloroquine, quinine, strychnopentamine 
(1) and isostrychnopentamine (2) (see Table 2). Chrysopentamine presented an IC50 around 
500 nM against all tested Plasmodium lines. Compound 3 possessed a comparable activity 
against all chloroquine-resistant and -sensitive lines of P. falciparum, which is indicative of 
the absence of cross-resistance with chloroquine. Compared with other indolic anhydronium 
bases or quaternary alkaloids, such as tetradehydrolongicaudatine Y or guianensine [5], 
compound 3 exhibits the strongest antiplasmodial activity of this class of compounds. 
 
Chrysopentamine (3), which exhibits strong antiplasmodial properties, is a novel 
indolomonoterpenoid alkaloid, which has five nitrogen atoms, an unusual phenolic 
substitution on C-14, and a pyridinium ring which put the alkaloid in the relatively small 
family of indolic anhydronium bases. 
 
Materials and Methods 
General Experimental Procedures: UV, IR, CD and NMR  spectrometers and procedures 
have been described previously [15] (NMR spectra were measured with a Bruker Avance 500 
MHz spectrometer). The HRESI-MS were recorded on a Q-TOF III micromass spectrometer 
(Waters-Micromass, Manchester, UK). All solvents and current chemicals used were of 
analytical grade (Merck chemicals, VWR international). Plant Material: The leaves of 
Strychnos usambarensis Gilg were collected by one of the authors (L.A.) in Akagera  
National Park, Rwanda and identified by Dr A. J. M. Leeuwenberg. Voucher specimens of the 
plant were deposited in the herbarium of the National Botanical Garden of Belgium at Meise 
and in the herbarium of the Pharmaceutical Institute, at Liège (N° 1397). Extraction and 
Isolation: The leaves of S. usambarensis (767 g) were percolated with 20 l of EtOAc (pH 8) 
until complete extraction of alkaloids. The extract was dissolved in 1% HOAc, washed with 
CH2Cl2 and then repeatedly extracted with CH2Cl2 at pH 8. The combined CH2Cl2 extracts 
were concentrated to give 6.55 g crude alkaloid extracts. Three g of extract were then 
fractionated by MPLC on 180 g of  Merck LichroSpher 60 RP Select B (12 µm) with a 
gradient of acetonitrile in sodium heptane sulfonate (1g in 420 ml, fitted to pH 2 with H3PO4) 
(0 to 800 ml: 10% acetonitrile; 800 ml to 1.5 l: 15% acetonitrile; 1.3 to 1.8 l: 20% acetonitrile; 
1.8 to  5 l: 25% acetonitrile; 5 l to end: 30% acetonitrile), to give 80 mg of strychnophylline 
(200-400 ml), 30 mg of strychnofoline (500-600 ml), 20 mg of chrysopentamine (3) (2900-
3000 ml), 1g of strychnopentamine (1) (3200-3400 ml), 300 mg of 11-hydroxyusambarine 
(3700-4400 ml) and 600 mg of isostrychnopentamine (2) (4600-4800 ml). The fractions were 
precipitated by Mayer's reagent and each precipitate was dissolved in MeOH-Me2CO-H2O 
(6:2:1) and the alkaloids converted to the chloride by passage through an Amberlite® IRA-
420 column (VWR international). The fractions were detected by TLC (EtOAc/2-
PrOH/NH4OH, 90:8:2). Compound 1 was finally purified on a sephadex® LH20 (Amersham 
bioscience, Roosendaal, The Netherlands) column with methanol as mobile phase. 
Chrysopentamine (3):  
Orange amorphous powder; coloration yellow, orange and red in solution, respectively at pH 
3, 9 and 12; UV (MeOH+CH3COOH 1%) λmax (log ε) = 231 (3.37), 290 (2.92), 320 (2.67), 
457 (3.12); UV (MeOH) λmax (log ε) = 231 (3.37), 290 (2.92), 325 (2.67), 469 (3.12); UV 
(MeOH+NH4OH 1%) λmax (log ε) = 231 (3.37), 290 (2.92), 325 (2.67), 469 (3.12); UV 
(MeOH+KOH 0.1 M 1%) λmax (log ε) = 231 (3.37), 292 (2.92), 360 (2.67), 510 (3.12); IR υmax 
(KBr) 3391, 2925, 2852, 1724 (w), 1622, 1589, 1554, 1450, 1308, 1255, 1232, 1157, 1119, 
1039, 922, 804, 743, 599 cm-1; CD (MeOH) nm (Δε) 218 (-6.25), 230 (+3.13), 244 (-0.52), 
274 (+1.06), 293 (-0.25); 1H (400 MHz) and 13C (100 MHz) NMR data are given in Table 1; 
ESIMS m/z 560 [MH+] (90), 519 (10), 376 (100), 185 (10); HRESIMS m/z [MH+] 560.3044 
(calcd for C35H38N5O2, 560.3026 ). Plasmodium falciparum cell lines and assays: Three 
Plasmodium falciparum cell lines were used in this study. These strains, the culture 
conditions and assay procedures were described previously [15-19]. Chloroquine diphosphate 
(Sigma C6628), and quinine base (Aldrich 14590-4) were used as antimalarial references.  
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Table 1 
1H and 13C NMR spectral data of chrysopentamine (3) (recorded at 500/125 MHz in 
MeOD). 
 







C-H correlations  
2     126.69 (q) 6, 21 
3     133.78 (q) 5, 21 
5 4.67 (t, 7.4) 21, 6 6 6, 21 57.14 (CH2) 21, 6 
6 3.28 (m) 5 5 5, 9 24.03 (CH2) 5 
7     114.79 (q) 5, 6, 9, 10 
8     120.28 (q) 10, 9, 6 
9 7.39 (d, 8.6) 10 10 6, 10 120.02 (CH) - 
10 6.72 (d, 8.6) 9 9 9 113.62 (CH) - 
11     155.92 (q) 2", 10, 9 
12     108.40 (q) 2", 10, 9 
13     138.74 (q) 2", 9, 10 
14     162.46 (q) 16ab, 21 











32.04 (CH2) - 
17 (3´) 4.63 (m) 16ab 16ab 22, 16a, 16b 61.73 (CH) 16b, 5´b, 22, 5´a 
18a 
18b 
5.45 (d, 17.2) 






18a, 21, 19 
120.17 (CH2)  - 
19 6.95 (dd, 11, 18) 21, 18ab 18ab 19b,  132.42 (CH) 21, 18b 
20     135.38 (q) 21, 18ab, 16b 
21 7.77 (s) 19, 5 - 5, 18b 127.28 (CH) 5 
N4´ Me (22) 2.95 (s) - - 17, 5´ab 41.39 (CH3) 5´b 









5´b, 6´, 22 
5´a, 22 









5´ab 18.62 (CH2) 5´a 
7´     107.66 (q) 5´ab, 6´, 9´ 
8´     127.41 (q) 9´, 10´, 12´ 
9´ 7.44 (d, 7.9) 10´, 11´ 10´, 11´, 12´ 10´ 119.06 (CH) 11´, 10´, 12´ 
10´ 7.02 (t, 7.3) 9´, 11´, 12´ 9´, 11´, 12´ 11´, 9´ 120.28 (CH) 12´ 
11´ 7.11 (t, 7.3) 10´, 12´, 9´ 9´, 10´, 12´ 10´, 12´ 123.07 (CH) 9´, 12´, 10´ 
12´ 7.30 (d, 8.1) 11´, 10´ 9´, 10´, 11´ 11´ 112.16 (CH) 10´, 9´, 11´ 
13´     138.28 (q) 9´, 11´ 
N1" Me (23) 2.46 (s) - - 5"ab, 2" 40.73 (CH3) 2", 5"a 





3"b, 2", 4" 
3"a, 2",  4" 
3"b, 4", 5"ab, 2" 
3"a, 4", 5"ab, 2" 
3"b 
3"a,  4" 














5"b, 4", 3"ab, 2" 
5"a, 4", 3"ab, 2" 
5"b, 4", 23 
5"a, 4", 23 
57.14 (CH2) 23, 3"b,  
a Chemical shifts (δ) in ppm from TMS. Multiplicities and coupling constants in Hz are in parentheses. b Carbon 
multiplicities in parentheses were deduced from APT spectrum  c Correlations from C to the indicated 
hydrogens.  
Table 2 
In vitro antiplasmodial activity of chrysopentamine (3), isostrychnopentamine (1), strychnopentamine (2), quinine, and chloroquine against 




FCA 20/ Ghana  
(chloroquine-sensitive line) 
FCB1-R / Colombia  
(moderately chloroquine-resistant line)
W2 / Indochina (Laos) 
 (chloroquine-resistant line) 
 IC50  nM  ± SDa IC90 nM  nb IC50  nM  ± SDa IC90  nM nb IC50  nM  ± SDa IC90  nM nb 
Strychnopentamine (1) 117 ± 33 443 4 N.D.c N.D.c  145 ± 20 2982 4 
Isostrychnopentamine (2) 120 ± 42 450 2 104 ± 36 386 3 152 ± 9 628 2 
Chrysopentamine (3) 579 ± 376 1918 2 550 ± 149 1980 6 507 ± 227 1774 2 
quinine 269 ± 6 1910 3 200 ± 33 2740 4 413 ± 11 1720 3 
chloroquine 11 ± 5 71 6 32 ± 19 84 3 284 ± 17 1750 5 
a.  Values are expressed as mean ± standard deviation. All tests were realized in duplicate.  
b.  “n” = number of experiments. 




























































Isostrychnopentamine (2): H-2´´ β
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